Clinical Trial Update: Role of Aprotinin in Glucagon Degradation, Measurement by Radioimmunoactive Method (RIA) I125 [NA]

View source ↗

Summary

This completed trial evaluated the role of aprotinin in glucagon degradation, measured by I125 radioimmunoassay, in hyperglucagonemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglucagonemia

Drugs mentioned

• Aprotinin (aprotinin)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Hyperglucagonemia | NA | Status: COMPLETED